The announcement of renegotiated contingent payments to the vendors of Medimark Scientific is seen very positively as it enables the integration of the two businesses to begin immediately, rather than waiting until April. We expect the integration to generate both cost synergies as well as revenue synergies as the established salesforce at Medimark cross-sells some of the Byotrol product range. A final payment of c.£290k will be paid, in addition to the issuance of 9.36m shares, compari
30 Jan 2020
Byotrol - Renegotiated contingent payments fast-track integration
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Byotrol - Renegotiated contingent payments fast-track integration
Byotrol plc (BYOT:LON) | 0.2 0 (-60.0%) | Mkt Cap: 0.68m
- Published:
30 Jan 2020 -
Author:
Mark Brewer | Cavendish Research -
Pages:
4
The announcement of renegotiated contingent payments to the vendors of Medimark Scientific is seen very positively as it enables the integration of the two businesses to begin immediately, rather than waiting until April. We expect the integration to generate both cost synergies as well as revenue synergies as the established salesforce at Medimark cross-sells some of the Byotrol product range. A final payment of c.£290k will be paid, in addition to the issuance of 9.36m shares, compari